Control group:Jinhua Qinggan granules simulation (placebo) agent: 1 sachet each time, 3 times daily after meal, dissolve in boil water.

2 trials

Sponsors

Center for Bioequivalence Studies and Clinical Research,Beijing Hospital of Traditional Chinese Medicine

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Phase 4

Multi-center, Randomized, Double Blind and Placebo Controlled Clinical Trial on the Efficacy and Safety of Jinhua Qinggan Granules (JHQG) for the Treatment of COVID-19 Patients.

Active, not recruitingITMCTR2000003697

Center for Bioequivalence Studies and Clinical Research,Beijing Hospital of Traditional Chinese MedicineNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-09-01Updated: 2023-02-20

Multi-center, Randomized, Double Blind and Placebo Controlled Clinical Trial on the Efficacy and Safety of Jinhua Qinggan Granules (JHQG) for the Treatment of COVID-19 Patients.

Active, not recruitingChiCTR2000036871

Center for Bioequivalence Studies and Clinical Research,Beijing Hospital of Traditional Chinese MedicineNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-09-01Updated: 2020-11-09